Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
200'S Series Novel Combinations (Dopamine Pathway) by Alto Neuroscience for Neurodegenerative Diseases: Likelihood of Approval
200'S Series Novel Combinations (Dopamine Pathway) is under clinical development by Alto Neuroscience and currently in Phase I for Neurodegenerative...